Elevai Labs, Inc. (NASDAQ:ELAB) Sees Significant Drop in Short Interest

Elevai Labs, Inc. (NASDAQ:ELAB) saw a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 19,400 shares, a decrease of 89.6% from the February 13th total of 185,700 shares. Approximately 0.6% of the company’s stock are short sold. Based on an average daily volume of 302,600 shares, the days-to-cover ratio is currently 0.1 days.

Elevai Labs Stock Up 8.4 %

ELAB stock traded up $0.35 during trading on Thursday, hitting $4.46. 19,109 shares of the stock traded hands, compared to its average volume of 305,178. Elevai Labs has a 1 year low of $3.88 and a 1 year high of $1,134.00. The firm’s 50 day moving average is $12.36 and its two-hundred day moving average is $97.62. The stock has a market cap of $2.57 million, a price-to-earnings ratio of -0.07 and a beta of -2.93. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.86 and a quick ratio of 3.40.

About Elevai Labs

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.